Literature DB >> 3756084

Risk of contralateral breast cancer in Denmark 1943-80.

H H Storm, O M Jensen.   

Abstract

The incidence of a second primary breast cancer in the contralateral breast among 56,237 women with a first primary breast cancer diagnosed between the years 1943-80 in Denmark was established. The relative risk (RR) for a breast cancer patient to get yet another breast cancer was studied, taking account of age, stage and treatment of the first primary breast cancer. Based on 345,573 women years at risk and 1,840 non simultaneous contralateral breast cancer cases the overall relative risk (RR) of invasive cancer in the contralateral breast following a first primary breast cancer, was found to be 2.8 (95% Confidence Interval (CI); 2.7-3.0). Among women who survived 10 or more years the risk was higher among those irradiated for the primary breast cancer (RR = 2.6) than among non-irradiated (RR = 2.0). In the large group of patients with localized disease the association with radiation was obvious for all ages combined (irradiated RR = 3.0, not irradiated RR = 1.6), but not obvious among premenopausal (age less than 45 years) and perimenopausal (age 45-54 years) women at primary breast cancer until followed for 20 years. The RR was higher among irradiated than non-irradiated post-menopausal (age greater than 55 years) women from the time of diagnosis of the first cancer, but was not significant after 14 years of follow-up. The probability for a woman diagnosed with breast cancer at 45 years of age or younger, of developing a contralateral breast cancer if surviving to the age of 75 years, is 25%. Close surveillance of the remaining breast of breast cancer patients is advised, especially if young or following an irradiated localized primary breast cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3756084      PMCID: PMC2001612          DOI: 10.1038/bjc.1986.201

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Comparative Studies of Cancerous Versus Noncancerous Breasts.

Authors:  F W Foote; F W Stewart
Journal:  Ann Surg       Date:  1945-02       Impact factor: 12.969

2.  Breast cancer in families.

Authors:  D E Anderson
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

3.  Breast cancer in Japanese A-bomb survivors.

Authors:  M Tokunaga; C E Land; T Yamamoto; M Asano; S Tokuoka; H Ezaki; I Nishimori
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

4.  Low-dose radiation--a cause of breast cancer?

Authors:  C E Land
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

5.  Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.

Authors:  M Tokunaga; J E Norman; M Asano; S Tokuoka; H Ezaki; I Nishimori; Y Tsuji
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

6.  Breast cancer following irradiation of the breast.

Authors:  E Baral; L E Larsson; B Mattsson
Journal:  Cancer       Date:  1977-12       Impact factor: 6.860

7.  Bilateral primary breast cancer: a prospective study of disease incidence.

Authors:  M A Chaudary; R R Millis; E O Hoskins; M Halder; R D Bulbrook; J Cuzick; J L Hayward
Journal:  Br J Surg       Date:  1984-09       Impact factor: 6.939

8.  Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women.

Authors:  C E Land; J D Boice; R E Shore; J E Norman; M Tokunaga
Journal:  J Natl Cancer Inst       Date:  1980-08       Impact factor: 13.506

9.  Leukaemia after cervical cancer irradiation in Denmark.

Authors:  H H Storm; J D Boice
Journal:  Int J Epidemiol       Date:  1985-09       Impact factor: 7.196

10.  Radiation dose and second breast cancer.

Authors:  V E Basco; A J Coldman; J M Elwood; M E Young
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

View more
  11 in total

Review 1.  Secondary malignancies across the age spectrum.

Authors:  Andrea K Ng; Lisa B Kenney; Ethel S Gilbert; Lois B Travis
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

2.  Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk.

Authors:  Robert T Chatterton; Richard E Heinz; Angela J Fought; David Ivancic; Claire Shappell; Subhashini Allu; Susan Gapstur; Denise M Scholtens; Peter H Gann; Seema A Khan
Journal:  Horm Cancer       Date:  2016-02-22       Impact factor: 3.869

3.  Cancer registries in epidemiologic research.

Authors:  H H Storm
Journal:  Cancer Causes Control       Date:  1996-05       Impact factor: 2.506

Review 4.  The increasing use of prophylactic mastectomy in the prevention of breast cancer.

Authors:  Todd M Tuttle; Andrea Abbott; Amanda Arrington; Natasha Rueth
Journal:  Curr Oncol Rep       Date:  2010-01       Impact factor: 5.075

5.  Prognostic significance of synchronous and metachronous bilateral breast cancer.

Authors:  J Kollias; I O Ellis; C W Elston; R W Blamey
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

Review 6.  Routine contralateral breast biopsy: helpful or irrelevant? Experience in 871 patients, 1979-1993.

Authors:  H S Cody
Journal:  Ann Surg       Date:  1997-04       Impact factor: 12.969

7.  The pattern of diagnosis of a second primary tumor in the breast.

Authors:  E Robinson; G Rennert; R Bar-Deroma; D L Dori; A I Neugut
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Role of preoperative magnetic resonance imaging in the surgical management of early-stage breast cancer.

Authors:  Sheenu Chandwani; Prethibha A George; Michelle Azu; Elisa V Bandera; Christine B Ambrosone; George G Rhoads; Kitaw Demissie
Journal:  Ann Surg Oncol       Date:  2014-06-10       Impact factor: 5.344

Review 9.  Is there a role for IGF-1 in the development of second primary cancers?

Authors:  Thurkaa Shanmugalingam; Cecilia Bosco; Anne J Ridley; Mieke Van Hemelrijck
Journal:  Cancer Med       Date:  2016-10-13       Impact factor: 4.452

10.  Heritable breast cancer in twins.

Authors:  T M Mack; A S Hamilton; M F Press; A Diep; E B Rappaport
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.